China releases preliminary reimbursement list

In its first full revision since 2017, China's National Medical Insurance Administration released a preliminary National Reimbursement Drug List, calling for price negotiations on 128 drugs. The new list is slated to go into effect on January 1, 2020.

128 exclusive patented drugs designated as high-priced by the agency have been identified as potential additions to the list after price negotiations, according to state run news outlet Xinhua. The government's next step is to confirm the sponsoring companies' intent to negotiate and separately release the list of negotiated drugs...